New study below [1].
A post on the possible influence of vasectomy on PCa development might seem like navel gazing at this point, but the subject continues to interest me.
When the first "bad news" about vasectomy was published long ago, the reaction was unexpected. Rather than warn men about to be snipped that there might be a PCa risk, the response was that the study results could not be correct because it was unthinkable that men throughout the world would reject the vasectomy option. There was seemingly more concern over the implications for women rather than men.
There are now enough studies that one could cherry-pick based on one's gut view, but the new study provides a plausible explanation for risk.
The team used "mice that underwent vasectomy vs. sham surgery". Very clever - the mice never knew which arm they were in. LOL. A molecule that was up-regulated in vasectomized mice was ZKSCAN3 [Zinc finger protein with KRAB and SCAN domains 3].
There was also "... increased ZKSCAN3 expression in adenocarcinoma vs. prostatic intraepithelial neoplasia (PIN), PIN vs. non-neoplastic prostate, Grade Group ≥3 vs. ≤2 tumors, pT3 vs. pT2 tumors, pN1 vs. pN0 tumors, and prostate cancer from patients with a history of vasectomy."
"Additionally, strong (2+/3+) ZKSCAN3 expression ... as an independent prognosticator, or vasectomy ... was associated with the risk of tumor recurrence."
The authors have an unusual rats nest of affiliations - two have 5.
My vasectomy was 42 years ago (26 years before diagnosis.) Did it increase my risk? Possibly, but it's of academic interest at this point. So many risk factors on the long road to diagnosis.
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/328...
Cancers (Basel)
. 2020 Aug 15;12(8):E2295. doi: 10.3390/cancers12082295.
Impact of Vasectomy on the Development and Progression of Prostate Cancer: Preclinical Evidence
Takashi Kawahara 1 2 3 4 , Yuki Teramoto 1 5 , Yi Li 1 , Hitoshi Ishiguro 1 2 3 6 7 , Jennifer Gordetsky 1 8 9 , Zhiming Yang 1 , Hiroshi Miyamoto 1 2 3 5 8
Affiliations collapse
Affiliations
1 Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
2 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
3 James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
4 Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
5 James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.
6 Kanagawa Institute of Industrial Science and Technology, Kawasaki 210-0821, Japan.
7 Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
8 Department of Urology, University of Rochester Medical Center, Rochester, NY 14642, USA.
9 Departments of Pathology and Urology, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
PMID: 32824199 DOI: 10.3390/cancers12082295
Abstract
Some observational studies have implied a link between vasectomy and an elevated risk of prostate cancer. We investigated the impact of vasectomy on prostate cancer outgrowth, mainly using preclinical models. Neoplastic changes in the prostate were compared in transgenic TRAMP mice that underwent vasectomy vs. sham surgery performed at 4 weeks of age. One of the molecules identified by DNA microarray (i.e., ZKSCAN3) was then assessed in radical prostatectomy specimens and human prostate cancer lines. At 24 weeks, gross tumor (p = 0.089) and poorly differentiated adenocarcinoma (p = 0.036) occurred more often in vasectomized mice. Vasectomy significantly induced ZKSCAN3 expression in prostate tissues from C57BL/6 mice and prostate cancers from TRAMP mice. Immunohistochemistry showed increased ZKSCAN3 expression in adenocarcinoma vs. prostatic intraepithelial neoplasia (PIN), PIN vs. non-neoplastic prostate, Grade Group ≥3 vs. ≤2 tumors, pT3 vs. pT2 tumors, pN1 vs. pN0 tumors, and prostate cancer from patients with a history of vasectomy. Additionally, strong (2+/3+) ZKSCAN3 expression (p = 0.002), as an independent prognosticator, or vasectomy (p = 0.072) was associated with the risk of tumor recurrence. In prostate cancer lines, ZKSCAN3 silencing resulted in significant decreases in cell proliferation/migration/invasion. These findings suggest that there might be an association between vasectomy and the development and progression of prostate cancer, with up-regulation of ZKSCAN3 expression as a potential underlying mechanism.